1. 1q21 gain but not t(4;14) indicates inferior outcomes in multiple myeloma treated with bortezomib. Issue 5 (15th April 2020) Authors: Du, Chenxing; Mao, Xuehan; Xu, Yan; Yan, Yuting; Yuan, Chenglu; Du, Xin; Liu, Jiahui; Fan, Huishou; Wang, Qi; Sui, Weiwei; Deng, Shuhui; Fu, Mingwei; Li, Zengjun; Li, Chengwen; Zhao, Jiawei; Yi, Shuhua; Liu, Lanting; Hao, Mu; Zou, Dehui; Zhao, Yaozhong Journal: Leukemia & lymphoma Issue: Volume 61:Issue 5(2020) Page Start: 1201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma. Issue 2 (9th December 2022) Authors: Li, Ru; Wang, Tingyu; Lyv, Rui; Wang, Yi; Yu, Ying; Yan, Yuting; Sun, Qi; Xiong, Wenjie; Liu, Wei; Sui, Weiwei; Huang, Wenyang; Wang, Huijun; Li, Chengwen; Wang, Jun; Zou, Dehui; An, Gang; Wang, Jianxiang; Qiu, Lugui; Yi, Shuhua Journal: Blood science Issue: Volume 5:Issue 2(2023) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma. Issue 7 (July 2015) Authors: Li, Fei; Hao, Mu; Feng, Xiaoyan; Zang, Meirong; Qin, Yu; Yi, Shuhua; Li, Zengjun; Xu, Yan; Zhou, Lili; Sui, Weiwei; Deng, Shuhui; Zou, Dehui; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia research Issue: Volume 39:Issue 7(2015:Jul.) Page Start: 793 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Multiple myeloma–derived miR‐27b‐3p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment. Issue 1 (15th January 2023) Authors: Wei, Xiaojing; Yu, Zhen; Tang, Peixia; Sun, Hao; Gong, Lixin; Liu, Lanting; Fang, Teng; He, Yi; Wang, Tingyu; Sui, Weiwei; Xu, Yan; An, Gang; Xu, Zhenshu; Ma, Xiaoke; Qiu, Lugui; Hao, Mu Journal: Clinical and translational medicine Issue: Volume 13:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Phase 1 study of C-CAR088, a novel humanized anti-BCMA CAR T-cell therapy in relapsed/refractory multiple myeloma. Issue 9 (13th September 2022) Authors: Qu, Xiaoyan; An, Gang; Sui, Weiwei; Wang, Tingyu; Zhang, Xian; Yang, Junfang; Zhang, Yan; Zhang, Lu; Zhu, Dan; Huang, Jiaqi; Zhu, Shigui; Yao, Xin; Li, Jing; Zheng, Chengxiao; Zhu, Kevin; Wei, Yutian; Lv, Xiaoteng; Lan, Liping; Yao, Yihong; Zhou, Daobin Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prognostic value of high serum lactate dehydrogenase in plasma cell dyscrasias: a re-evaluation in the context of cytogenetic aberration data. Issue 11 (November 2013) Authors: An, Gang; Shi, Lihui; Xu, Yan; Zou, Dehui; Deng, Shuhui; Sui, Weiwei; Zhu, Guoqing; Xie, Zhenqing; Hao, Mu; Sun, Qi; Zhan, Fenghuang; Qiu, Lugui Journal: Leukemia & lymphoma Issue: Volume 54:Issue 11(2013:Nov.) Page Start: 2556 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Synthesis of Hydrophobic Polymeric Cryogels with Supermacroporous Structure. Issue 6 (1st March 2016) Authors: Chen, Xilu; Sui, Weiwei; Ren, Dayong; Ding, Yuanyuan; Zhu, Xiaoli; Chen, Zhiyong Journal: Macromolecular materials and engineering Issue: Volume 301:Issue 6(2016) Page Start: 659 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria. Issue 12 (15th October 2022) Authors: Yan, Wenqiang; Fan, Huishou; Xu, Jingyu; Liu, Jiahui; Li, Lingna; Du, Chenxing; Deng, Shuhui; Sui, Weiwei; Hao, Mu; Yi, Shuhua; Zou, Dehui; Qiu, Lugui; Xu, Yan; An, Gang Journal: Leukemia & lymphoma Issue: Volume 63:Issue 12(2022) Page Start: 2955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma. Issue 1 (31st December 2023) Authors: Fan, Huihsou; Yan, Wenqiang; Li, Lingna; Xu, Jingyu; Liu, Jiahui; Xu, Yan; Sui, Weiwei; Deng, Shuhui; Du, Chenxing; Yi, Shuhua; Zou, Dehui; Qiu, Lugui; An, Gang Journal: Hematology Issue: Volume 28:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma. (30th July 2021) Authors: Lyu, Rui; Wang, Tingyu; Wang, Yi; Xiong, Wenjie; Wang, Huijun; Yan, Yuting; Wang, Qi; Liu, Wei; An, Gang; Huang, Wenyang; Sui, Weiwei; Xu, Yan; Zou, Dehui; Wang, Jianxiang; Qiu, Lugui; Yi, Shuhua Journal: British journal of haematology Issue: Volume 194:Number 5(2021) Page Start: 862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗